What are the advantages of flow control ventilation compared to pressure control ventilation (PCV) and volume control ventilation (VCV) in critically ill patients requiring mechanical ventilation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flow Control Ventilation Compared to Pressure and Volume Control Ventilation

Direct Answer

The provided evidence does not contain any information about "flow control ventilation" as a distinct ventilatory mode, and therefore no advantages can be established from the available guidelines and research. The evidence exclusively discusses volume control ventilation (VCV), pressure control ventilation (PCV), and related modes, but does not address flow control ventilation as a separate entity.

What the Evidence Actually Shows

Volume Control vs Pressure Control: The Real Comparison

The available high-quality guidelines and research focus on comparing VCV and PCV, not flow control ventilation:

Volume Control Ventilation Should Be Initial Mode

  • VCV is recommended as the initial mode for patients with ARDS requiring passive mechanical ventilation because it ensures delivery of lung-protective tidal volumes (4-8 mL/kg predicted body weight) and facilitates measurement of plateau pressure and driving pressure 1, 2.
  • VCV guarantees fixed tidal volume delivery, which is essential for implementing the lung-protective ventilation strategy that has demonstrated mortality reduction in ARDS patients 2.
  • VCV allows automatic collection of plateau pressure and driving pressure during inspiratory pause, critical measurements for assessing lung stress and titrating PEEP appropriately 2.

Pressure Control Has Specific Advantages in Assisted Breathing

  • Transition from VCV to PCV when switching from controlled to assisted invasive mechanical ventilation as patient recovery allows, prioritizing patient comfort and synchrony 2, 3.
  • PCV offers superior respiratory comfort during assisted breathing because it does not limit inspiratory flow, allowing the ventilator to match variable patient demand 2, 3.
  • In patients with ALI/ARDS during assisted ventilation, PCV significantly reduced patient work of breathing compared to VCV (0.59 ± 0.42 J/L vs 0.70 ± 0.58 J/L, p < 0.05), attributed to higher ventilator peak inspiratory flow with PCV (103.2 ± 22.8 L/min vs 43.8 L/min) 4.

No Mortality Difference Between Modes

  • Meta-analysis of three RCTs with 1,089 participants showed no clear mortality benefit: hospital mortality RR 0.83 (95% CI 0.67 to 1.02), ICU mortality RR 0.84 (95% CI 0.71 to 0.99), and 28-day mortality RR 0.88 (95% CI 0.73 to 1.06) 5.
  • Comparisons of PCV and VCV did not show any difference for compliance, gas exchange, hemodynamics, work of breathing, or clinical outcomes in systematic reviews 6.

Clinical Algorithm for Mode Selection

Step 1: Early ARDS/Passive Ventilation

  • Start with VCV in assist-control mode at 6 mL/kg predicted body weight 1, 2.
  • Maintain plateau pressure ≤30 cmH₂O and driving pressure <15 cmH₂O 1, 2.
  • VCV ensures consistent alveolar ventilation when compliance or airway resistance changes acutely 3.

Step 2: Transition to Assisted Breathing

  • Switch to PCV when reducing sedation and allowing spontaneous breathing efforts 2, 3.
  • PCV provides better patient-ventilator synchrony and comfort during assisted breathing 2, 3.
  • Monitor for rebreathing potential with PCV bi-level systems, especially in tachypneic patients with respiratory rates >20/min 3.

Step 3: Special Circumstances Requiring VCV

  • When reducing tidal volume from 6 mL/kg to 4 mL/kg predicted body weight for plateau pressures >30 cmH₂O 3.
  • When ensuring consistent minute ventilation during permissive hypercapnia 3.
  • When patients fail on pressure support and consistent alveolar ventilation is crucial 3.

Critical Pitfalls to Avoid

  • Do not use high tidal volumes (>8-10 mL/kg PBW) in any mode, as this increases mortality risk 1.
  • During PCV, monitor arterial blood gases closely for unexpected hypercapnia from rebreathing, especially if respiratory rate increases 3.
  • Ensure exhalation ports are functioning properly during PCV to prevent occlusion by sputum, which can exacerbate hypercapnia through rebreathing 3.
  • VCV requires clinicians to appropriately set inspiratory flow, flow waveform, and inspiratory time, while PCV determines these automatically 7.
  • Both modes can achieve lung protection when tidal volume, plateau pressure, and driving pressure are appropriately managed 3.

Related Questions

What are the differences between VC+ (Volume Control) mode and regular VC (Volume Control) mode in terms of flow delivery and patient suitability?
What is the difference between pressure control ventilation (PCV) and volume control ventilation (VCV) in a patient with acute respiratory distress syndrome (ARDS)?
What is the preferred ventilation mode, pressure control mode or volume control mode, for a patient requiring mechanical ventilation, particularly those with acute respiratory distress syndrome (ARDS) or chronic obstructive pulmonary disease (COPD)?
What is the preferred mode of ventilation, pressure control ventilation (PCV) or volume control ventilation (VCV), for a patient with respiratory distress, particularly those with acute respiratory distress syndrome (ARDS) or heterogeneous lung injury?
In which conditions is pressure control ventilation (PCV) preferred over volume control ventilation?
Is metformin (biguanide oral hypoglycemic) safe for a female patient with polycystic ovary syndrome (PCOS) and metabolic risks, including hypertriglyceridemia and hypercholesterolemia, to use during breastfeeding?
Is cefadroxil a suitable oral antibiotic option for a patient with a moderate to severe infection, who has previously required intravenous cefotaxime, considering their medical history, age, renal function, and allergy status?
Do antihistamines have a role in acute colds?
What is the management approach for a patient with Hemophagocytic Lymphohistiocytosis (HLH) presenting with a cholestatic liver pattern that may progress to fulminant hepatitis?
What are the most common causes of acute decompensated heart failure in older adults with a history of cardiovascular disease?
Can metformin lower cholesterol in a breastfeeding woman with PCOS and hypercholesterolemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.